Synlait Milk: A Leader in New Zealand's Dairy Industry

Synlait Milk stands out in New Zealand's dairy sector, known for producing high-quality dairy products, including milk powders and infant formulas. The company's dedication to innovation and sustainability has cemented its role in the global dairy market.

Company Facilities and Locations

Synlait Milk is headquartered in Dunsandel, Canterbury, which is central to its operations. The company also operates the Pōkeno Manufacturing Facility on New Zealand's North Island, which is vital for expanding production. Additionally, Synlait has blending and canning operations in Auckland, focusing on value-added dairy products.

Financial Indicators

In the past fiscal year, Synlait Milk reported a revenue of NZD 1.3 billion. Despite this, the company faced a net loss of NZD 39.8 million due to operational challenges and market volatility. For the financial year ending July 31st, 2026, Synlait recorded a net loss of $75.4 million, with revenue increasing by 6% to $1.94 billion, although gross profit fell by 64% to $37.7 million.

Recent Significant Events

A strategic review of Synlait Milk's North Island assets, including the Pōkeno manufacturing facility and Auckland's blending and canning operations, was recently completed. This review aims to enhance operational efficiency and align assets with long-term goals. The company is also involved in the EcoPond pilot project on 250 farms, focusing on sustainability. Manufacturing challenges at the Dunsandel site were also highlighted.

Company Plans

Synlait Milk focuses on increasing operational efficiency, especially at the Pōkeno and Auckland sites. The company aims to reduce carbon emissions and waste along its supply chain as part of its sustainability initiatives. In exploring new international markets, Synlait seeks to diversify its revenue streams. Investment in R&D to develop high-value dairy products is also a priority. A significant strategy includes selling its North Island assets to Abbott Laboratories for NZD 307 million, part of a financial recovery plan. Synlait has also increased its banking facility by NZD 50 million to manage manufacturing costs. A capital injection of NZD 217.8 million from major stakeholders like a2 Milk Company and Bright Dairy supports the company amid economic challenges and strategic shifts. Synlait has secured a NZD 320 million bank refinancing package, planning to reduce reliance on short-term financing by 2027. The company has concentrated manufacturing at Dunsandel and focuses on products such as pediatric nutrition, lactoferrin, and specialised foodservice lines.

Synlait Milk has appointed Leon Fung as its permanent chief executive. The company has been experiencing commercial volatility and is adjusting product volumes. It focuses on specialised protein fractionation and consumer-packaging products, and has been working with Bright Dairy on debt maturities and financing costs.